Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Femasys Inc (FEMY)

Femasys Inc (FEMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed GlobeNewswire - Tue Dec 3, 8:00AM CST

FEMY : 1.0900 (-0.91%)
Femasys Inc. Publishes Positive Data from Pivotal FemaSeed® Trial in Journal of Gynecology & Reproductive Medicine Quiver Quantitative, Inc. - Tue Nov 26, 5:52PM CST

Femasys announces positive results for FemaSeed® intratubal insemination, demonstrating improved pregnancy rates in a pivotal clinical trial.Quiver AI SummaryFemasys Inc. announced the publication of...

FEMY : 1.0900 (-0.91%)
Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment GlobeNewswire - Tue Nov 26, 7:30AM CST

FEMY : 1.0900 (-0.91%)
Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update GlobeNewswire - Tue Nov 12, 7:30AM CST

FEMY : 1.0900 (-0.91%)
Femasys to Exhibit at the Annual AAGL 2024 Global Conference GlobeNewswire - Thu Nov 7, 7:30AM CST

FEMY : 1.0900 (-0.91%)
Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control GlobeNewswire - Fri Nov 1, 7:30AM CDT

FEMY : 1.0900 (-0.91%)
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed GlobeNewswire - Wed Oct 30, 8:00AM CDT

FEMY : 1.0900 (-0.91%)
Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program GlobeNewswire - Thu Oct 10, 7:30AM CDT

FEMY : 1.0900 (-0.91%)
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit GlobeNewswire - Tue Oct 8, 7:30AM CDT

FEMY : 1.0900 (-0.91%)
Author
5 of the Most Active Penny Stocks Worth Your Precious Time MarketBeat - Thu Oct 5, 2023

These are five of the Most Active Penny Stocks in October that investors may find worthy of investment for 2024 and beyond

CHPT : 1.2400 (+8.77%)
SABR : 3.86 (+1.58%)
FEMY : 1.0900 (-0.91%)
NKLA : 1.1800 (+0.85%)
GRAB : 4.90 (-0.41%)

Barchart Exclusives

How To Profit From The Latest Corporate Spinoffs: A Guide For Investors In 2025 Barchart - 32 minutes ago
How to navigate corporate spinoffs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot